Falsified Medicines Directive: Your Time Starts … Now!

Add bookmark
The Falsified Medicines Directive (FMD) has been labeled as a ‘slow and arduous process to: ‘ratify and may be equally difficult to implement’ (1), with some pharma companies being relatively gradual in the renovation of their product lines.   Industry analysts have identified that the major re-engineering demanded for packaging lines is a large, invasive and expensive task - with some questioning as to whether the three year window given will be achievable especially for smaller firms. (1)...

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended